Noninvasive High Frequency Oscillatory Ventilation as a Post-extubation Respiratory Support in Neonates

August 7, 2022 updated by: Sondos Ahmed Salaheldin Ahmed, Ain Shams University

Noninvasive High Frequency Oscillatory Ventilation as a Post-extubation Respiratory Support in Preterm Neonates: A Randomized Controlled Trial

A randomized controlled trial comparing Noninvasive high frequency oscillatory ventilation (NHFOV) and Noninvasive positive pressure ventilation (NIPPV) as post-extubation respiratory support in preterm neonates with respiratory distress syndrome(RDS)

Study Overview

Detailed Description

The use of noninvasive respiratory support (NRS) has increased in recent decades in Neonatal Intensive Care Unit (NICU) as a means to reduce ventilator-induced lung injury. Various modes of NRS are available and in common use. However despite extensive research, the optimal modality of noninvasive modes remain unknown.

Noninvasive high-frequency oscillatory ventilation (NHFOV) is a relatively new mode. It consists of the application of a continuous distending positive pressure with superimposed oscillations. It is a method of augmenting Continuous positive airway pressure (CPAP) support potentially combining the advantages of both high-frequency oscillatory ventilation and CPAP.

The new NHFOV technique offers improved carbon dioxide (CO2) removal and increased functional residual capacity. The superimposed oscillations of NHFOV are thought to help avoid gas trapping and upregulate mean airway pressure.

This technique is also characterized by lower tidal volume resulting in fewer barotraumas /volutraumas and not needing synchronization. NHFOV was considered a strengthened version of CPAP.

The hypothesis is that NHFOV might be superior to NIPPV as a post-extubation respiratory support strategy to avoid reintubation and subsequent complications and/or sequelae in preterm infants.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 minute to 1 month (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Preterm neonates with gestational age ≤ 35 weeks.
  2. Neonates that were on invasive mechanical ventilation for at least 48 hours eligible for extubation

Exclusion Criteria:

  1. Patients with major upper or lower airway anomalies.
  2. Patients with significant congenital anomalies including cardiac, abdominal or respiratory.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: noninvasive high frequency oscillatory ventilation (NHFOV)
After documenting parental consent, the ventilated infants eligible for extubation were randomly assigned to NHFOV as post extubation noninvasive respiratory support

A time-cycled, pressure-limited, and continuous-flow neonatal ventilator (SLE6000; SLE) was used for neonates assigned to the NHFOV group. The settings were as follows:

  1. a frequency of 10 Hertz ( range, 8-12 Hz);
  2. an inspiratory time of 50% (1:1)
  3. an oscillation amplitude of 35 centimeter of water column (cmH2O) (subsequent regulation range, 20-40 cmH2O) Oscillation amplitude would be regulated according to the level of carbon dioxide(CO2). Visible chest oscillation was not necessary because elimination of CO2 during NHFOV could also occur in the upper respiratory airway dead space
  4. Mean airway pressure (MAP) of 10 cm H2O ( range, 7-15) MAP was regulated according to an open lung recruitment strategy
  5. fraction of inspired oxygen (FIO2) regulated from 0.21 to 0.40 in order to maintain saturation from 90% to 95% as determined with a pulse oximeter.
Active Comparator: noninvasive positive pressure ventilation (NIPPV)
After documenting parental consent, the ventilated infants eligible for extubation were randomly assigned to NIPPV as post extubation noninvasive respiratory support

NIPPV will be delivered by ventilator generating the targeted pressures. Infants will be on:

  1. Peep ranging from 5 to 10 cmH2O,
  2. Peak inspiratory pressure range 15-25 cmH2O
  3. Rate range 40-50 breath/minute
  4. FIO2 regulated from 0.21 to 0.40 in order to maintain saturation from 90% to 95% as determined with a pulse oximeter.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Re-intubation rate
Time Frame: 72 hours
Percentage of Patients who failed weaning on the assigned noninvasive mode and needed reintubation to the total number of patients assigned to that mode.
72 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Days on the assigned non-invasive respiratory support
Time Frame: 8 weeks or till patient discharge which comes first
To document number of days on the assigned non-invasive respiratory support
8 weeks or till patient discharge which comes first
Days on supplemental oxygen
Time Frame: 8 weeks or till patient discharge which comes first
To document number of days on supplemental oxygen
8 weeks or till patient discharge which comes first
Duration of admission
Time Frame: 8 weeks or till patient discharge which comes first
To document total number of days of admission
8 weeks or till patient discharge which comes first
Mortality rate
Time Frame: 8 weeks or till patient death which comes first
To document incidence of mortality during hospitalization
8 weeks or till patient death which comes first
Lung ultrasound score
Time Frame: Before extubation and after 2 hours on assigned mode
lung ultrasound was performed to all patients before extubation and 2 hours after extubation to assess lung aeration. Score ranges from 0 to 18 .Higher score indicates worse lung aeration.
Before extubation and after 2 hours on assigned mode
Co2 change
Time Frame: Before extubation and after 2 hours on assigned mode
Co2 change in patients on assigned mode using venous blood gases performed before extubation and 2 hours after.
Before extubation and after 2 hours on assigned mode
Oxygen requirement
Time Frame: Before extubation and after 2 hours on assigned mode
Fraction of inspired oxygen required to patients on assigned mode
Before extubation and after 2 hours on assigned mode
Incidence of feeding intolerance
Time Frame: 8 weeks or till patient weaning from assigned mode which comes first
Percentage of Patients who developed feeding intolerance on the assigned noninvasive mode to the total number of patients assigned to that mode.
8 weeks or till patient weaning from assigned mode which comes first
Days to reach full intake
Time Frame: 8 weeks or till patient discharge which comes first
Number of days needed by each patient to reach full intake
8 weeks or till patient discharge which comes first
Intracranial hemorrhage
Time Frame: 8 weeks or till patient weaning from assigned mode which comes first
Percentage of patients developing intracranial hemorrhage on the assigned noninvasive mode to the total number of patients assigned to that mode.
8 weeks or till patient weaning from assigned mode which comes first
Pneumothorax
Time Frame: 8 weeks or till patient weaning from assigned mode which comes first
Percentage of patients developing pneumothorax on the assigned noninvasive mode to the total number of patients assigned to that mode.
8 weeks or till patient weaning from assigned mode which comes first
Incidence of occurrence of Nasal trauma
Time Frame: 8 weeks or till patient weaning from assigned mode which comes first
Percentage of patients developing nasal trauma on the assigned noninvasive mode to the total number of patients assigned to that mode.
8 weeks or till patient weaning from assigned mode which comes first
incidence of bronchopulmonary dysplasia
Time Frame: 8 weeks or till patient discharge which comes first
Need for supplemental oxygen for at least 28 days, percentage of these patients on the assigned noninvasive mode to the total number of patients assigned to that mode.
8 weeks or till patient discharge which comes first
Severity of respiratory distress
Time Frame: Before extubation and and after 2 hours on assigned mode
Assessment of work of breathing on assigned mode by Downe 's score. Score ranges from 0 till 10 . Higher score indicates worse work of breathing.
Before extubation and and after 2 hours on assigned mode
Need for Postnatal Steroids
Time Frame: 8 weeks or till patient discharge which comes first
Percentage of patients who needed postnatal steroids administration
8 weeks or till patient discharge which comes first
Chest x ray change
Time Frame: Before extubation and and after 2 hours on assigned mode
Chest x ray grading of RDS performed to patient before and after the assigned mode to compare lung aeration degree.
Before extubation and and after 2 hours on assigned mode

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2021

Primary Completion (Anticipated)

August 15, 2022

Study Completion (Anticipated)

August 30, 2022

Study Registration Dates

First Submitted

August 3, 2022

First Submitted That Met QC Criteria

August 7, 2022

First Posted (Actual)

August 9, 2022

Study Record Updates

Last Update Posted (Actual)

August 9, 2022

Last Update Submitted That Met QC Criteria

August 7, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Tract Diseases

Clinical Trials on noninvasive high frequency oscillatory ventilation

Subscribe